RecruitingNot applicableNCT07545473

Retinal Hyperspectral Imaging in Neurodegenerative Diseases

Studying Central retinal artery occlusion

Last synced from ClinicalTrials.gov May 6, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Center for Eye Research Australia
Intervention: Hyperspectral camera(device)
Enrollment: 930 target
Eligibility: 30 years · All sexes
Timeline: 2021 – 2028

Study locations (1)

The Centre for Eye Research Australia, Melbourne, Victoria, Australia

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07545473 on ClinicalTrials.gov

Other trials for Central retinal artery occlusion

Additional recruiting or active studies for the same condition.

RECRUITINGNCT07482228
Long-term Clinical Outcomes After Retinal Artery Occlusion
Chonnam National University Hospital
RECRUITINGNANCT07151755
Microneedle Intra-Arterial Injection for Retinal Artery Occlusion
Second Affiliated Hospital, School of Medicine, Zhejiang University
RECRUITINGNCT06500728
Visual Involvement in Giant Cell Arteritis
ASST Fatebenefratelli Sacco
RECRUITINGPHASE3NCT04965038
Early Reperfusion Therapy With Intravenous Thrombolysis for Recovery of VISION in Acute Central Retinal Artery Occlusion
University Hospital Tuebingen

See all trials for Central retinal artery occlusion →

← Back to all trials